Duarte, CA1 Active Studies

Paroxysmal Nocturnal Hemoglobinuria Clinical Trials in Duarte, CA

Find 1 actively recruiting paroxysmal nocturnal hemoglobinuria clinical trials in Duarte, CA. Connect with local research sites and explore new treatment options.

1
Active Trials
1
Sponsors
32
Enrolling

Recruiting Paroxysmal Nocturnal Hemoglobinuria Studies in Duarte

About Paroxysmal Nocturnal Hemoglobinuria Clinical Trials in Duarte

Paroxysmal nocturnal hemoglobinuria (PNH) is a rare, acquired blood disease where the immune system destroys red blood cells, causing dark-colored urine, fatigue, and blood clots. It is caused by a genetic mutation in blood stem cells. Treatment includes complement inhibitors like eculizumab.

There are currently 1 paroxysmal nocturnal hemoglobinuria clinical trials recruiting participants in Duarte, CA. These studies are seeking a combined 32 participants. Research is being sponsored by Lakefront Biotherapeutics West LLC. Clinical trial participation is free and participants receive study-related medical care at no cost.

Paroxysmal Nocturnal Hemoglobinuria Clinical Trials in Duarte — FAQ

Are there paroxysmal nocturnal hemoglobinuria clinical trials in Duarte?

Yes, there are 1 paroxysmal nocturnal hemoglobinuria clinical trials currently recruiting in Duarte, CA. Browse the studies on this page to find one that fits.

How do I join a clinical trial in Duarte?

Browse the studies listed above, click one that interests you, and complete the free eligibility form. A study coordinator at the Duarte research site will contact you about next steps.

Are clinical trials in Duarte free?

Yes, clinical trial participation is always free. Study-related treatment, medical tests, and doctor visits are provided at no cost. Many Duarte studies also compensate for your time and travel.

What paroxysmal nocturnal hemoglobinuria treatments are being tested?

The 1 active trials in Duarte are testing new therapies including novel drugs, biologics, and treatment approaches for paroxysmal nocturnal hemoglobinuria.

Data updated October 14, 2026 from ClinicalTrials.gov